2 of 5 | NGUYEN include but are not limited to: psychosis, Alzheimer's disease, diabetic retinopathy and type 2 diabetes, uremia, alcoholism, and as part of nutritional studies. [1] [2] [3] [4] [5] [6] [7] Most investigations now use liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) to observe particular phospholipids of interest. To our knowledge, to date, no method has been described incorporating solid-phase extraction (SPE) techniques, which specifically target phospholipids from red blood cells based on their amphiphilic properties. Seen as an alternative to traditional liquid-liquid extraction, SPE has several advantages, most notably a reduction in solvent use and the ability to be incorporated with other sample preparation procedures. 8 Against this backdrop, in this short, report we aimed to develop and validate a simple SPE method for analyzing red cell phospholipids that can be easily incorporated and undertaken in laboratories with access to LC-MS/MS.
| ME THODS AND MATERIAL S

| Ethics
This study was conducted in compliance with the National Health and 
| Biosamples
Erythrocyte samples used for method development and validation were obtained from a consenting healthy volunteer. Whole blood samples were collected in Vacuette ® 4 mL EDTA tubes. For these samples, the plasma layer was separated and the red cells were washed three times with isotonic saline solution and then lysed with ultrapure water. All specimens were stored at −20°C until use. 
| Chemicals and reagents
| Sample preparation
An aliquot of 250 μL of the red cell lysate was used to extract phos- 
| Instrumentation and conditions
The main instrumentation used was a LC-MS/MS system (LC- Chromatographic separation of PE species was undertaken in reverse phase by an ACE C4 column (150 mm × 2.1 mm, 2.7 μm particle size) equipped with a Rheodyne column inlet filter 
| Method validation
Method validation was performed with definitions of the parameters, including recovery, accuracy, linearity and range, precision, limit of detection (LOD), and limit of quantification (LOQ).
The linear range was defined between 10 and 500 μg/L for both PE species. The accuracy and precision of the method were measured by repeat analysis of our high and low QC samples. Between-and within-run precision and accuracy were calculated using the above procedure but repeated on at least seven different days. To assess recovery, a set of calibration standards was prepared in water at three levels 100, 300, and 500 μg/L for both PE species. Recovery was assessed by comparing calibrators made up in pure solutions (water) and not subject to the full sample preparation procedure (representing 100% recovery) to calibrators made up of biological matrices, which were subjected to the full sample preparation procedure. This was repeated at least seven times at each concentration. The LOQ was set at our lowest calibration standard. The LOD was determined by serial dilution of our LOQ until a signal-to-noise ratio of 3:1 was established.
| Method application
The method developed was tested and applied onto a cohort of 12 consenting healthy volunteers to measure the presence of both phospholipid species.
| RE SULTS
The 6-point calibration curves for both phospholipid species being examined displayed daily correlation coefficients (r 2 )
always greater than .99 (n = 15) in the range of 10 to 500 μg/L.
A sample chromatogram positive for both species is displayed in Figure 1A ,B. No interfering peaks were observed. The coefficients of variation (CVs) for PE 16:0/18:1 concerning intraday precision was between 1.9% and 2.6% and for interday precision, it was between 3.0% and 4.3% ( and PE 16:0/18:2: 92%-102%) ( Table 1 ). The limit of detection was determined to be 5 μg/L. The varying levels of both phospholipid species present within our cohort tested (n = 12) are displayed in Table 2 .
| D ISCUSS I ON
In this study, we developed and validated a simple SPE method for recovery. Furthermore, we tested our method in a small cohort of healthy volunteers and were able to successfully measure varying levels of both phospholipid species. Our SPE method uses a commercial zirconia-coated cartridge, which allows for the selective retention of phospholipids. This particular type of cartridge has been previously investigated and determined to be successful at reducing/removing phospholipid based matrix effects. 9 In our study instead, we piloted the use of Hybrid-SPE to research a straightforward means of obtaining and analyzing red cell phospholipids. To our knowledge, the application of this form of SPE in the context of recovering solely red cell phospholipids has never been reported before. In our procedure, no column conditioning or washing was involved. Only a one-step sample "load and elute"
process was required following sample precipitation. Overall, this equates to a fast and efficient sample preparation process.
Finally, it must be noted that we only researched two phospholipids of interest and consequently, future areas of investigation should further explore the applicability of this method in other different types of phospholipids. However, as all phospholipids have the same base structures with amphiphilic properties (due to the polar head group and nonpolar tail), we believe this method does have promise and will be suitable for analyzing all red cell phospholipids.
In conclusion, we propose a validated simple SPE method for analyzing phospholipids in erythrocytes, which can be easily adopted in laboratories with access to LC-MS/MS.
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